Company profilePharmaceutical#1122 of 1,318 in Pakistan✓ No DRAP alerts

Jaskan pharmaceuticals Pvt Ltd

Pharmaceutical company · 2 brands · 3 molecules

Ranked #131 of 137 companies in Anti-Infectives

2 registered products 3 pharmaceutical brands 3 distinct molecules 0 DRAP alerts

Company overview

2
registered products
3
pharmaceutical brands
3
distinct molecules
1
therapeutic classes
0
DRAP alerts

Jaskan pharmaceuticals Pvt Ltd is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 2 product registrations across 3 distinct molecules. Its portfolio is concentrated in Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Jaskan

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 1

Top molecules by brand count

Inf1 brand
Amlodipine1 brand

Therapeutic classes

Anti-Infectives · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 722.58 – Rs 722.58
Servaid1 products · Rs 584.2 – Rs 584.2
Median across source: Rs 722.58

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

HIGH - Q INTERNATIONAL holds 138 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAnastrozoleAprepitant
BOSCH PHARMACEUTICALS (PVT) LTD. holds 154 molecules not in this portfolio
AmikacinAmlodipineAmoxicillinAmoxicillin SodiumAmoxicillin …50Mg Clavulanic Acid 12.5 MgAmoxycillin
HELIX PHARMA (PRIVATE) LIMITED holds 112 molecules not in this portfolio
000 I.UAmlodipineAmylaseArtemetherArtesunateAscorbic Acid

Get the full profile for Jaskan

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.